Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
22.75
-2.43 (-9.65%)
At close: Oct 16, 2026, 4:00 PM EDT
23.00
+0.25 (1.10%)
After-hours: Oct 16, 2026, 7:50 PM EDT
Parabilis Medicines Earnings Call Transcripts
Fiscal Year 2026
-
The Helicon platform enables targeting of undruggable proteins, with Zolucatetide showing strong efficacy and safety in desmoid tumors and promising early results in FAP and ACP. Phase III trials, pipeline expansion, and a Regeneron partnership are underway, supported by $1.1B in cash.